What is Bluu Biosciences?
Bluu Biosciences operates at the intersection of biotechnology and food science, specializing in the development of cultivated fish products. By leveraging advanced cellular technology, the company aims to produce high-quality seafood directly from fish cells, effectively bypassing the environmental and ethical concerns associated with industrial aquaculture and overfishing. As a key player in the alternative protein landscape, Bluu Biosciences is strategically positioned to disrupt the global seafood market by offering a scalable, sustainable, and nutrient-dense alternative to conventional fish, thereby contributing to a more resilient and environmentally conscious food supply chain.
How much funding has Bluu Biosciences raised?
Bluu Biosciences has raised a total of $25.9M across 2 funding rounds:
Angel/Seed
$8.4M
Series A
$17.5M
Angel/Seed (2021): $8.4M with participation from CPT Capital, DX Ventures, Manta Ray Ventures, Norrsken Vc, Be8, and Lever VC
Series A (2023): $17.5M led by Delivery Hero and Manta Ray Ventures
Key Investors in Bluu Biosciences
CPT Capital
CPT Capital is an investment firm focused on the future of food and materials, specifically in the alternative protein sector, partnering with visionary founders to replace animals in the supply chain.
Manta Ray Ventures
Manta Ray is an early stage venture capital fund that supports mission-driven founders tackling significant global challenges through advanced technologies and patient capital.
Norrsken VC
Norrsken VC is Europe's leading early-stage impact investor, focusing on companies that address significant global challenges while achieving substantial business growth.
What's next for Bluu Biosciences?
With the successful completion of its latest financing, Bluu Biosciences is poised to transition from laboratory-scale development to pilot-scale production. The company's strategic roadmap focuses on optimizing cell cultivation processes to achieve cost parity with conventional seafood, a critical milestone for mass-market adoption. Furthermore, the firm is expected to deepen its regulatory engagement and expand its intellectual property portfolio, ensuring a competitive edge in the rapidly evolving food technology sector. By leveraging its recent capital injection, Bluu Biosciences will likely prioritize scaling its operations and establishing key partnerships within the food distribution ecosystem to bring its cultivated seafood products to consumers across international markets.
See full Bluu Biosciences company page
